Virtual brain and electroencephalography explain the variance of memory alterations in mild cognitive impairment

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background Mild Cognitive Impairment (MCI) is a heterogeneous clinical condition characterized by a wide spectrum of cognitive and behavioural manifestations. Despite numerous studies, the link between neuropsychological performance and pathophysiological signatures of the disease - including Aβ and tau accumulation along with altered excitation/inhibition (E/I) balance and brain rhythms - remains elusive. Methods Here Aβ/tau biomarkers were used to distinguish positive (MCI + - prodromal AD) and MCI subjects. Virtual brain models based on high-field MRI data were then developed to determine the inter-node coupling and E/I profile in resting-state networks, while node spectral information was obtained from source analysis of high-density electroencephalography (HD-EEG). Finally, virtual brains and HD-EEG parameters, creating brain digital twins of individual subjects, were correlated with cognitive performance. Results While virtual brain simulations did not reveal E/I differences between MCI + and MCI , a positive correlation emerged between synaptic parameters of the limbic network and verbal episodic memory for both groups. EEG power spectral density revealed a lower high-frequency/low-frequency ratio in MCI + largely due to a reduced alpha band in the default mode, limbic, attention, frontoparietal, visual and somatomotor networks. The combination of HD-EEG and virtual brain parameters explained up to 90% of patients’ variance in episodic memory scores, going beyond the sensitivity of individual measures alone. Conclusion This multimodal and multiparametric analysis combining virtual brain modelling with MRI, HD-EEG, and molecular data enhances the stratification of MCI patients and could be used to develop digital biomarkers of progression to dementia, opening new perspectives for personalized prognosis and treatment.

Article activity feed